scholarly article | Q13442814 |
P50 | author | William A. McEwan | Q54148397 |
Susanna R Bidgood | Q59137182 | ||
Gregory Towers | Q59210726 | ||
P2093 | author name string | Donna L Mallery | |
Leo C James | |||
Chris M Johnson | |||
P2860 | cites work | Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains | Q24543332 |
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function | Q24684586 | ||
TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved | Q27650357 | ||
Pathogen recognition and innate immunity | Q27861084 | ||
Retroviral restriction factor TRIM5alpha is a trimer | Q34123929 | ||
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody | Q36642588 | ||
Postabsorption neutralization of poliovirus | Q36647081 | ||
Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization | Q36909792 | ||
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. | Q36974763 | ||
Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection. | Q37109301 | ||
Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q | Q38503914 | ||
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms | Q40128651 | ||
Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion | Q44243033 | ||
Studies on the mechanism of the enzymatic reactivation of antibody-neutralized poliovirus. | Q44409566 | ||
Adenovirus-mediated expression of green fluorescent protein | Q45883272 | ||
TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain | Q53587210 | ||
Origin of Antibody Variation | Q59057486 | ||
Characteristics of the new respiratory viruses (adenoviruses). I. Qualitative and quantitative aspects of the neutralization reaction | Q64386084 | ||
Neutralization of poliovirus by a monoclonal antibody: Kinetics and stoichiometry | Q70151362 | ||
P433 | issue | 46 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P1104 | number of pages | 6 | |
P304 | page(s) | 19985-19990 | |
P577 | publication date | 2010-11-02 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) | |
P478 | volume | 107 |
Q24619754 | A Class of Human Proteins that Deliver Functional Proteins into Mammalian Cells In Vitro and In Vivo |
Q37938942 | A Conserved Host and Pathogen Recognition Site on Immunoglobulins: Structural and Functional Aspects |
Q47151370 | A Method for the Acute and Rapid Degradation of Endogenous Proteins. |
Q47105994 | A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway |
Q36781367 | A pathogenic picornavirus acquires an envelope by hijacking cellular membranes |
Q90467720 | A tri-ionic anchor mechanism drives Ube2N-specific recruitment and K63-chain ubiquitination in TRIM ligases |
Q64245708 | A walk through tau therapeutic strategies |
Q36438451 | AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. |
Q92139780 | Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model |
Q91705437 | Acute and rapid degradation of endogenous proteins by Trim-Away |
Q47547452 | Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. |
Q35664117 | Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System |
Q28661395 | An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family |
Q86422882 | An inside job for antibodies: tagging pathogens for intracellular sensing |
Q41955482 | Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. |
Q28743313 | Antibodies against alpha-synuclein reduce oligomerization in living cells |
Q37015487 | Antibodies and their receptors: different potential roles in mucosal defense. |
Q27316185 | Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy |
Q93004236 | Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection |
Q27322604 | Antibody to Ricin A Chain Hinders Intracellular Routing of Toxin and Protects Cells Even after Toxin Has Been Internalized |
Q42213058 | Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica. |
Q37853942 | Antibody-Fc receptor interactions in protection against intracellular pathogens. |
Q40437803 | Antibody-antigen kinetics constrain intracellular humoral immunity |
Q33867299 | Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design |
Q50513813 | Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? |
Q49789469 | Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen Neutralization |
Q89495822 | Autoantibodies reactive to PEP08 are clinically related with morbidity and severity of interstitial lung disease in connective tissue diseases |
Q36026299 | Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus |
Q30397773 | Biological and immunotoxicity evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on titanium |
Q92096254 | CF-PA2Vtech: a cell-free human protein array technology for antibody validation against human proteins |
Q26864521 | Cellular Self-Defense: How Cell-Autonomous Immunity Protects Against Pathogens |
Q50058338 | Characterization of innate immune viral sensors in patients following allogeneic hematopoietic stem cell transplantation. |
Q91510932 | Characterization of porcine tripartite motif genes as host restriction factors against PRRSV and PEDV infection |
Q37180418 | Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes |
Q36469094 | Clinical and pathological roles of Ro/SSA autoantibody system. |
Q34186473 | Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis |
Q38568860 | Co-evolution with chicken class I genes. |
Q57292399 | Collusion between neutralizing antibodies and other immune factions in the destruction of adenoviral vectors |
Q40121690 | Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain SCHU S4. |
Q64058164 | Complement C4 Prevents Viral Infection through Capsid Inactivation |
Q33686907 | Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies |
Q28078936 | Coordinated Neutralization and Immune Activation by the Cytosolic Antibody Receptor TRIM21 |
Q37598940 | Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. |
Q58764815 | Cytosolic Internalization of Anti-DNA Antibodies by Human Monocytes Induces Production of Pro-inflammatory Cytokines Independently of the Tripartite Motif-Containing 21 (TRIM21)-Mediated Pathway |
Q27654848 | Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity |
Q36821602 | Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus |
Q61444985 | Degradation of endogenous proteins and generation of a null-like phenotype in zebrafish using Trim-Away technology |
Q35961267 | Delicate coordination of TRIM21's dual activity in virus neutralization and signaling |
Q90239647 | Ehrlichia chaffeensis Outer Membrane Protein 1-Specific Human Antibody-Mediated Immunity Is Defined by Intracellular TRIM21-Dependent Innate Immune Activation and Extracellular Neutralization |
Q26766715 | Engineered IgG1-Fc--one fragment to bind them all |
Q91741458 | Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease |
Q91910378 | Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues |
Q33774072 | Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet's disease |
Q50066373 | Epstein–Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by theSynechococcusphage |
Q47553316 | Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field |
Q35960506 | Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5 |
Q55000106 | Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways. |
Q47844351 | FCRLA-A Resident Endoplasmic Reticulum Protein that Associates with Multiple Immunoglobulin Isotypes in B Lineage Cells. |
Q33729303 | FTR83, a Member of the Large Fish-Specific finTRIM Family, Triggers IFN Pathway and Counters Viral Infection |
Q47202386 | Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex |
Q26783175 | Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases |
Q38239276 | Fc receptors as adaptive immunoreceptors |
Q38615396 | Fc receptors in antibody-dependent enhancement of viral infections |
Q39217862 | Fcγ Receptor Heterogeneity in Leukocyte Functional Responses. |
Q49372307 | Francisella tularensis Confronts the Complement System |
Q41741684 | Functions of Antibodies. |
Q37566736 | Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1. |
Q38307864 | Getting across the cell membrane: an overview for small molecules, peptides, and proteins |
Q48105494 | Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum |
Q55022148 | High-resolution definition of humoral immune response correlates of effective immunity against HIV. |
Q40054966 | Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses |
Q36646919 | Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals |
Q47593481 | Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon |
Q34324992 | Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies |
Q64118813 | IgG and Fcγ Receptors in Intestinal Immunity and Inflammation |
Q34368678 | IgG subclasses and allotypes: from structure to effector functions |
Q49713864 | Immune response against the coiled coil domain of Sjögren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction. |
Q28554212 | Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells |
Q37899064 | Immunotherapy for tauopathies. |
Q54210526 | Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction |
Q37718852 | Innate immunity to adenovirus |
Q34114819 | Interferon-inducible effector mechanisms in cell-autonomous immunity |
Q52650219 | Intracellular Antiviral Immunity |
Q38203800 | Intracellular antibody immunity |
Q87557035 | Intracellular antibody immunity and the cytosolic Fc receptor TRIM21 |
Q37049349 | Intracellular antibody receptor TRIM21 prevents fatal viral infection |
Q55044025 | Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21. |
Q36903830 | Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. |
Q34319249 | Intracellular immunity: finding the enemy within--how cells recognize and respond to intracellular pathogens |
Q83367806 | Intracellular neutralisation of adenovirus by antibody |
Q35546930 | Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. |
Q34231523 | Intracellular sensing of complement C3 activates cell autonomous immunity. |
Q36401357 | Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor. |
Q40511171 | Leukocyte immunoglobulin-like receptor B4 regulates key signalling molecules involved in FcγRI-mediated clathrin-dependent endocytosis and phagocytosis |
Q38187651 | Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors |
Q30431292 | Mass spectrometric and peptide chip characterization of an assembled epitope: analysis of a polyclonal antibody model serum directed against the Sjøgren/systemic lupus erythematosus autoantigen TRIM21 |
Q35927793 | Mast Cells and Company |
Q38773662 | Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model |
Q35599273 | Modeling of Human Cytomegalovirus Maternal-Fetal Transmission in a Novel Decidual Organ Culture |
Q37860624 | Modulation of antibody effector function |
Q36243864 | Molecular basis of antibody mediated immunity against Ehrlichia chaffeensis involves species-specific linear epitopes in tandem repeat proteins |
Q38633596 | Monoclonal antibodies: technologies for early discovery and engineering |
Q36438404 | More than one way to TRIM a capsid |
Q38615349 | Mouse and human FcR effector functions |
Q40295939 | Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives |
Q45740034 | Non‐neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement |
Q87417220 | Novel approach to identifying autoantibodies in rheumatoid synovitis with a biotinylated human autoantigen library and the enzyme-labeled antigen method |
Q37113941 | Opportunities to exploit non-neutralizing HIV-specific antibody activity |
Q40604291 | Optimization of protein-protein docking for predicting Fc-protein interactions. |
Q33971228 | Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish |
Q30577235 | PKA-dependent dynein switching from lysosomes to adenovirus: a novel form of host-virus competition |
Q39208140 | Peering into the 'black box' of pathogen recognition by cellular autophagy systems |
Q30541128 | Polarized cell migration during cell-to-cell transmission of herpes simplex virus in human skin keratinocytes |
Q34992787 | Polyreactivity and autoreactivity among HIV-1 antibodies |
Q39013521 | Post-translational Control of Intracellular Pathogen Sensing Pathways |
Q98939407 | Post-translational modifications inducing proteasomal degradation to counter HIV-1 infection |
Q37547441 | Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication |
Q40909612 | Protein Composition of Immunoprecipitated Synaptic Ribbons |
Q64061300 | Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer |
Q34151113 | QTL for white spot syndrome virus resistance and the sex-determining locus in the Indian black tiger shrimp (Penaeus monodon) |
Q52718401 | Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters. |
Q36172040 | Regulation of Virus Neutralization and the Persistent Fraction by TRIM21 |
Q38256371 | Regulation of fc receptor endocytic trafficking by ubiquitination. |
Q37914113 | Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins |
Q56893551 | Respiratory syncytial virus vaccine development |
Q48507985 | Review of Current Cell-Penetrating Antibody Developments for HIV-1 Therapy. |
Q39114608 | Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies |
Q33736516 | Role of Fc in antibody-mediated protection from ricin toxin |
Q35295003 | Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo |
Q93081484 | Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle |
Q54216752 | Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus. |
Q87981875 | Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21 |
Q39868227 | Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats |
Q42438365 | Separation of Function between Isotype Switching and Affinity Maturation In Vivo during Acute Immune Responses and Circulating Autoantibodies in UNG-Deficient Mice |
Q35961313 | Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21 |
Q43107406 | Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21. |
Q36394195 | Stonefish toxin defines an ancient branch of the perforin-like superfamily. |
Q27678419 | Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity |
Q38058751 | Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity |
Q27670990 | Structure of the rhesus monkey TRIM5 PRYSPRY domain, the HIV capsid recognition module |
Q90312477 | Surveillance for Intracellular Antibody by Cytosolic Fc Receptor TRIM21 |
Q59358033 | TRIM Proteins and Their Roles in Antiviral Host Defenses |
Q89965638 | TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis |
Q38787430 | TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity |
Q99571935 | TRIM21 Is Targeted for Chaperone-Mediated Autophagy during Salmonella Typhimurium Infection |
Q35823139 | TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus |
Q36654167 | TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis |
Q33899190 | TRIM21 is critical for survival of Toxoplasma gondii infection and localises to GBP-positive parasite vacuoles. |
Q57292410 | TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination |
Q90290727 | TRIM21-From Intracellular Immunity to Therapy |
Q91663204 | TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity |
Q26779753 | TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity |
Q36760097 | TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation |
Q34442208 | TRIM38 Negatively Regulates TLR3-Mediated IFN-β Signaling by Targeting TRIF for Degradation |
Q36000845 | TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. |
Q90245595 | TRIM5α self-assembly and compartmentalization of the HIV-1 viral capsid |
Q38170892 | TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity |
Q38159081 | Tapping the treasure of intracellular oncotargets with immunotherapy |
Q58566968 | Targeted Intracellular Delivery of Antibodies: The State of the Art |
Q61799039 | Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis |
Q35687324 | The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease |
Q90211958 | The Ligands for Human IgG and Their Effector Functions |
Q38650844 | The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. |
Q34677183 | The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids. |
Q28072692 | The Peculiar Characteristics of Fish Type I Interferons |
Q64968356 | The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration. |
Q40075519 | The TRIMendous Role of TRIMs in Virus-Host Interactions |
Q38180345 | The function of Fcγ receptors in dendritic cells and macrophages |
Q35864160 | The proteome of postsurgical pancreatic juice |
Q37976998 | The role of tripartite motif family members in mediating susceptibility to HIV-1 infection |
Q40574579 | Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway |
Q34217953 | Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells |
Q37867107 | Trends in vaccine adjuvants. |
Q43089737 | Trim5 TAKes on pattern recognition |
Q36302384 | Tripartite Motif (TRIM) 12c, a Mouse Homolog of TRIM5, Is a Ubiquitin Ligase That Stimulates Type I IFN and NF-κB Pathways along with TNFR-Associated Factor 6 |
Q30414377 | UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV |
Q39317949 | Ubiquitin enzymes in the regulation of immune responses |
Q38559605 | Update on Pathogenesis of Sjögren's syndrome |
Q38193173 | Uptake, internalization and nuclear translocation of radioimmunotherapeutic agents |
Q64057499 | Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses |
Q37946075 | What tubulin drugs tell us about microtubule structure and dynamics |
Q33772637 | Which Antibody Functions are Important for an HIV Vaccine? |
Q36098311 | cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis. |
Q40006173 | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis |
Search more.